Valuation: Cencora, Inc.

Market Cap 59.89B 313B 51.72B 48.6B 44.2B 83.1B 5,726B 84.47B 569B 223B 2,868B 225B 220B 9,529B P/E 2026 *
17.2x
P/E 2027 * 18.8x
Enterprise Value 67.57B 354B 58.36B 54.84B 49.87B 93.77B 6,461B 95.31B 643B 251B 3,236B 254B 248B 10,752B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.76%
Yield 2027 * 0.78%
1 day-0.32%
3 months-7.03%
6 months-23.46%
Current year-25.57%
Current year 665.32
Extreme 665.32
952.48
1 year 665.32
Extreme 665.32
960
3 years 430.43
Extreme 430.43
960
5 years 309.44
Extreme 309.44
960
10 years 181.9
Extreme 181.9
960
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%-.--% - - 59.89B
-0.02%+3.19%-13.95%+4.85% 193B
+0.76%+4.72%-0.77%+9.75% 117B
+1.43%-2.07%+6.43%+67.25% 59.89B
+0.32%+3.92%+38.42%+65.14% 56.01B
+0.79%+3.70%-5.95%-35.11% 49.96B
-1.89%+5.90%+12.24%-22.47% 33.87B
+0.45%+1.45% - - 31.36B
+0.94%-1.31%+41.93%-12.62% 24.59B
+1.98%+12.62%-2.80%+25.91% 24.77B
Average +0.44%+3.69%+9.44%+12.84% 65.53B
Weighted average by Cap. +0.36%+3.41%+1.51%+13.55%

Financials

2026 *2027 *
Net sales 337B 1,765B 291B 274B 249B 468B 32,246B 476B 3,207B 1,254B 16,148B 1,266B 1,239B 53,661B 356B 1,863B 308B 289B 263B 494B 34,045B 502B 3,386B 1,324B 17,049B 1,337B 1,308B 56,655B
Net income 3.58B 18.73B 3.09B 2.91B 2.64B 4.97B 342B 5.05B 34.05B 13.31B 171B 13.44B 13.15B 570B 2.84B 14.89B 2.46B 2.31B 2.1B 3.95B 272B 4.01B 27.06B 10.58B 136B 10.68B 10.45B 453B
Net Debt 7.68B 40.21B 6.64B 6.24B 5.67B 10.66B 735B 10.84B 73.07B 28.57B 368B 28.85B 28.22B 1,223B 9.44B 49.38B 8.15B 7.66B 6.97B 13.1B 902B 13.31B 89.74B 35.09B 452B 35.43B 34.66B 1,502B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
313.82USD
Average target price
372.58USD
Spread / Average Target
+18.73%

Quarterly revenue - Rate of surprise